Drug of Abuse Testing Market Research Report Information by Type of Test (Onsite Screening Test and Laboratory Drug Testing), By Sample (Urine, Saliva, Hair, and others) and Region (North America, Europe, Asia-Pacific and the Rest of the World) - Forecast till 2032.

1 Research Scope & Methodology

1.1 Market Definition 10

1.2 Market Breakdown by Type of Tests, Sample 10

1.3 Market Breakdown by Geography 11

1.4 Research Methodology and Sources 11

2 Executive Summary

2.1 Key Findings 13

2.2 Research Summary 13

3 Market Outlook

3.1 Introduction 15

3.1.1 International Drug Trafficking 15

3.1.2 Drug Trafficking and Illicit Drug Use in North America 16

3.1.3 Drug Trafficking and Illicit Drug Use in Europe 16

3.1.4 Drug Trafficking and Illicit Drug Use in Asia-Pacific 16

3.2 Technology Analysis – Drug Abuse Testing Market 17

3.2.1 Chromatography Technology 17

3.2.2 Immunoassay Technology 17

3.3 Single vis-à-vis Multiple Parameter Test 18

3.4 Factors Driving the Market and its Impact on Market Forecast 19

3.4.1 Increased Use of Drug Testing at Organizational Level 19

3.4.2 Increased Production and Trade of Illicit Drugs Worldwide 20

3.4.3 Global Increase in Road Accidents and Death Rates 20

3.4.4 Increase in the Consumption of Illegal Drugs 20

3.4.5 Impact Analysis of Drivers on Market Forecast 21

3.5 Factors Hindering the Market and its Impact on Market Forecast 21

3.5.1 Legalization of Drugs 21

3.5.2 Social Issues Associated with Drug Abuse Testing 22

3.5.3 Inability of Testing Products to Detect Low-Dose Designer Drugs 22

3.5.4 Impact Analysis of Restraints on Market Forecast 23

4 Global Market Size & Forecast (2020-2027)

4.1 Global Market Breakdown by Type of Test 24

4.2 Global Market Breakdown by Sample 25

4.3 Global Market Breakdown by Region 27

5 Global Market Breakdown by Type of Test

5.1 Onsite Testing 29

5.2 Laboratory Testing 29

5.3 The North American Market by Type of Test 30

5.3.1 US Drugs of Abuse Market by Type of Test 32

5.4 The European Market by Type of Test 33

5.4.1 UK Drugs of Abuse Market, by Type of Test 34

5.4.2 Germany Drugs of Abuse Market by Type of Test 34

5.4.3 France Drugs of Abuse Market, by Type of Test 35

5.5 Asia-Pacific Market by Type of Test 36

5.5.1 India Drugs of Abuse Market by Type of Test 37

5.5.2 China Drugs of Abuse Market, by Type of Test 38

5.5.3 Japan Drugs of Abuse Market, by Type of Test 38

6 Global Market Breakdown by Sample

7 Global Market Breakdown by Region

7.1 North America Market Breakdown by Country 43

7.1.1 Drug Abuse Market Scenario in the US. 44

7.2 Europe Market Breakdown by Country 45

7.2.1 Drug Abuse Market Scenario in the UK. 46

7.2.2 Drug Abuse Market Scenario in France 46

7.2.3 Drug Abuse Market Scenario in Germany 47

7.3 Asia-Pacific Market Breakdown by Country 47

7.3.1 Drug Abuse Market Scenario in India 49

7.3.2 Drug Abuse Market Scenario in China 50

7.3.3 Drug Abuse Market Scenario in Japan 51

8 Competitive Analysis and Market Share

Porter's Five Forces of Competitive Position Analysis 52

8.1.1 Bargaining Power of Buyers 52

8.1.2 Bargaining Power of Suppliers 53

8.1.3 Threat of New Entrants 53

8.1.4 Intensity of Rivalry 53

8.1.5 Threat of Substitutes 53

9 Company Profiles

9.1 Roche Holding Limited 54

9.1.1 Business Overview 54

9.1.2 Products and Services 54

9.1.3 Recent Developments 55

9.2 Quest Diagnostics 55

9.2.1 Business Overview 55

9.2.2 Products and Services 56

9.2.3 Recent Developments 56

9.3 Laboratory Corporation of America Holdings 56

9.3.1 Business Overview 57

9.3.2 Products and Services 57

9.3.3 Recent Developments 57

9.4 Alere Inc. 58

9.4.1 Business Overview 58

9.4.2 Products and Services 58

9.4.3 Recent Developments 58

9.5 Abbott Laboratories 59

9.5.1 Business Overview 59

9.5.2 Products and Services 59

9.5.3 Recent Developments 60

9.6 Randox Laboratories Ltd 60

9.6.1 Business Overview 60

9.6.2 Products and Services 61

9.6.3 Recent Developments 62

9.7 Psychemedics Corporation 62

9.7.1 Business Overview 62

9.7.2 Products and Services 62

9.7.3 Recent Developments 62

9.8 Bio-Rad Laboratories, Inc. 63

9.8.1 Business Overview 63

9.8.2 Products and Services 63

9.8.3 Recent Developments 63

9.9 Sonic Healthcare 64

9.9.1 Business Overview 64

9.9.2 Products and Services 64

9.9.3 Recent Developments 65

9.10 Thermo Fisher Scientific Inc. 66

9.10.1 Business Overview 66

9.10.2 Products and Services 66

9.10.3 Recent Developments 67

10 Appendix

10.1 List of Abbreviations 68

11 List of Tables

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION 12

TABLE 2 GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT(2020 AND 2027) 14

TABLE 3 WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE(2027) 15

TABLE 4 MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST 19

TABLE 5 DRIVERS FOR THE MARKET: IMPACT ANALYSIS 21

TABLE 6 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS 23

TABLE 7 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 24

TABLE 8 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2027) 25

TABLE 9 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2020–2027) 26

TABLE 10 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2020–2027) 26

TABLE 11 GLOBAL MARKET BREAKDOWN BY REGION, $M (2020–2027) 27

TABLE 12 GLOBAL MARKET BREAKDOWN BY REGION, $M (2020–2027) 28

TABLE 13 ONSITE SCREENING TEST—ADVANTAGES AND DISADVANTAGES 29

TABLE 14 LABORATORY DRUG TEST—ADVANTAGES AND DISADVANTAGES 30

TABLE 15 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 31

TABLE 16 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 31

TABLE 17 US MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2020) 32

TABLE 18 US MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 32

TABLE 19 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2020) 33

TABLE 20 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 33

TABLE 21 UK MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 34

TABLE 22 UK MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 34

TABLE 23 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35

TABLE 24 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35

TABLE 25 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35

TABLE 26 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36

TABLE 27 ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36

TABLE 28 ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36

TABLE 29 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 37

TABLE 30 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 37

TABLE 31 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 38

TABLE 32 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 38

TABLE 33 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 39

TABLE 34 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 39

TABLE 35 SAMPLE ANALYSIS—ADVANTAGES AND DISADVANTAGES 40

TABLE 36 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2020–2027) 43

TABLE 37 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2020–2027) 44

TABLE 38 EUROPE MARKET BREAKDOWN BY REGION, $M (2020–2027) 45

TABLE 39 EUROPE MARKET BREAKDOWN BY REGION, $M (2020–2027) 46

TABLE 40 ASIA-PACIFIC MARKET BREAKDOWN BY REGION, $M (2020–2027) 49

TABLE 41 ASIA-PACIFIC MARKET BREAKDOWN BY REGION, $M (2020–2027) 49

TABLE 42 ROCHE HOLDINGS—KEY FACTS 54

TABLE 43 QUEST DIAGNOSTICS—KEY FACTS 55

TABLE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS—KEY FACTS 56

TABLE 45 ALEREINC—KEY FACTS 58

TABLE 46 ABBOTT LABORATORIES—KEY FACTS 59

TABLE 47 RANDOX LABORATORIES—KEY FACTS 60

TABLE 48 PSYCHEMEDICS CORPORATION—KEY FACTS 62

TABLE 49 BIO-RAD LABORATORIES—KEY FACTS 63

TABLE 50 SONIC HEALTHCARE—KEY FACTS 64

TABLE 51 THERMO FISHER SCIENTIFIC INC.—KEY FACTS 66

12 List of Figures

FIG 1 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 24

FIG 2 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2020) 25

FIG 3 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2020) 27

FIG 4 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 30

FIG 5 THE NORTH AMERICAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 31

FIG 6 THE EUROPEAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 33

FIG 7 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST, 2020 37

FIG 8 GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE, 2020 42

FIG 9 NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY(2020) 43

FIG 10 EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2020) 45

FIG 11 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2020) 48

FIG 12 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS 52